This broadly applicable, functional, RNA-based technology allows for rapid in vivo evolution of AAV capsids with desired cell-specific transduction properties in multiple species, including non ...

A fundamental challenge for cystic fibrosis (CF) gene therapy is ensuring sufficient transduction of airway epithelial cells to achieve therapeutic correction. Vehicles such as lysophosphatidylcholine ...